MALAT1 and lung carcinoma: Furthermore, the combined positive likelihood ratio suggested that the probability of positive expression of MALAT1 in lung cancer patients was 2.6 times higher than that in the control group, which further reflected the potential value of circulating MALAT1 in the diagnosis of lung cancer.